Yahoo Web Search

Search results

    • Health Care Roundup: Market Talk

      Health Care Roundup: Market Talk

      The Wall Street Journal· 2 hours ago

      Ionis down 4.9% to $37.30. (colin.kellaher@wsj.com) 0458 ET – Roche’s phase 1 weight loss efficacy results for its injectable dual GLP-1/GLP...

    • Q1 2024 Omeros Corp Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 2 hours ago

      Let's now turn to OMS906. Our MASP-3 inhibitor targeting the alternative pathway of complement. OMS906 is advancing well from multiple ongoing Phase 2 studies in two rare ...

    • Q1 2024 Panbela Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 7 hours ago

      I will start by discussing our clinical development program, recent achievements, and upcoming milestones. Then Sue will review our financial results before we open up the call for Q&A. Let ...